TELIX Pharmaceuticals Ltd (tlx) Logo

TELIX Pharmaceuticals Ltd (TLX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

TLX ASX Chart

Snapshot

Telix Pharmaceuticals Limited (TLX) is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. Telix is developing a portfolio of clinical stage products that aims to address unmet medical needs in oncology and rare diseases.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +47.08%
vs ASX 200 (1yr) +36.23%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 108 of 2,384
Sector Rank 9 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ANN / EBO / SNZ
EPS $0.016
DPS $0.00
Book Value Per Share $0.119

Broker Consensus

TLX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office North Melbourne VIC 3051
Website www.telixpharma.com
Registry Link Market Services
Auditor PricewaterhouseCoopers
Date Listed 15 Nov 2017

Upcoming Calendar (Forecasted)

Date Event
22/05/2024 AGM
21/08/2024 Report (Interim)
20/02/2025 Report (Prelim)
20/02/2025 Report (Annual)

Former Company Names

  • TELIX Pharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

TLX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
18/01/24 Christian Behrenbruch Buy +153,298 $11.00 $1,686,278 Exercise of options
18/01/24 Christian Behrenbruch Exercise 153,298 $11.00 $1,686,278 Exercise of options
18/01/24 Christian Behrenbruch Cancelled 46,702 $11.00 $513,722 Cancellation of securities
30/05/23 Christian Behrenbruch Issued 120,268 $2.97 $356,738 Director remuneration
16/03/23 Tiffany Olson Buy +51,305 $6.69 $343,385 On-market trade
12/12/22 Tiffany Olson Buy +10,930 $6.70 $73,255 On-market trade
09/11/22 Jann Skinner Issued 495,000 $1.09 $539,550 Exercise of options
09/11/22 Jann Skinner Exercise 495,000 $1.09 $539,550 Exercise of options
03/06/22 Tiffany Olson Buy +33,000 $4.11 $135,665 On-market trade
18/05/22 Christian Behrenbruch Issued 139,672 $2.43 $339,752 Issue of securities
18/05/22 Tiffany Olson Issued 52,070 $2.19 $113,850 Issue of securities
27/04/22 Oliver Buck Buy +250,000 $4.37 $1,092,500 On-market trade
03/02/22 Christian Behrenbruch Buy +400,000 $1.09 $436,000 Exercise of options
03/02/22 Christian Behrenbruch Exercise 400,000 $1.09 $436,000 Exercise of options
27/01/22 Christian Behrenbruch Sell +2,000,000 $7.70 ($15,400,000) As advised by the company
27/01/22 Andreas Kluge Sell +2,000,000 $7.70 ($15,400,000) As advised by the company
29/09/21 Mark Nelson Buy +990,000 $0.850 $841,500 Exercise of options
29/09/21 Mark Nelson Exercise 990,000 $0.850 $841,500 Exercise of options
29/09/21 Harry McCann Buy +990,000 $0.850 $841,500 Exercise of options
29/09/21 Harry McCann Exercise 990,000 $0.850 $841,500 Exercise of options
12/05/21 Christian Behrenbruch Issued 100,708 $3.71 $373,626 Issue of options
02/11/20 Oliver Buck Buy +165,330 $0.850 $140,530 Exercise of options
02/11/20 Oliver Buck Exercise 165,330 $0.850 $140,530 Exercise of options
12/05/20 Christian Behrenbruch Issued 200,000 $1.47 $294,000 Issue of options
27/02/20 Mark Nelson Buy +400,000 $1.45 $580,000 On-market trade
13/02/20 Oliver Buck Exercise 164,835 $0.850 $140,110 Exercise of options
13/02/20 Oliver Buck Buy +164,835 $0.850 $140,110 Exercise of options
13/02/20 Oliver Buck Buy +164,835 $0.850 $140,110 Exercise of options
13/02/20 Oliver Buck Exercise 164,835 $0.850 $140,110 Exercise of options
17/09/19 Oliver Buck Buy +164,835 $0.850 $140,110 Exercise of options
17/09/19 Oliver Buck Exercise 164,835 $0.850 $140,110 Exercise of options
13/09/18 Jann Skinner Buy +100,000 $0.850 $85,000 On-market trade

Director Interests

The current holdings of TLX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Tiffany Olson 22/02/2024 95,235 N/A 52,070 N/A
Mark Nelson 22/02/2024 N/A 3,628,750 N/A N/A
Andreas Kluge 22/02/2024 N/A 22,675,000 N/A N/A
Christian Behrenbruch 22/02/2024 400,000 22,675,000 560,648 N/A
Jann Skinner 22/02/2024 N/A 595,000 N/A N/A
Harry McCann 22/02/2024 1,150,000 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Jan 24, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees ( Limited 38,850,342 11.99%
J P Morgan Nominees Australia Pty Limited 34,966,849 10.79%
Citicorp Nominees Pty Limited 29,118,387 8.99%
Elk River Holdings Pty Ltd As Trustee For The Behrenbruch Family Trust And C Behrenbruch 22,675,000 7.00%
Gnosis Verwaltungsgesellschaftm B H 22,675,000 7.00%
National Nominees Limited 11,451,177 3.53%
Grand Decade Developments Limited 10,947,181 3.38%
Uv Cap Gmbh & Co Kg 7,454,500 2.30%
BNP Paribas Nominees Pty Ltd Acf Clearstream 6,623,660 2.04%
Bnp Paribas Noms Pty Ltd 6,279,603 1.94%
Bnp Paribas Nominees Pty Ltd i 5,978,960 1.85%
The Oncidium Foundation 5,929,331 1.83%
HSBC Custody Nominees (Australia) Limited A/C 2 4,017,015 1.24%
Lightpoint Medical Ltd 3,298,073 1.02%
Man Holdings Pty Ltd 3,228,750 1.00%
Bnp Paribas Nominees Pty Ltd ii 2,922,383 0.90%
Pacific Custodians Pty Limited 1,990,000 0.61%
Yelwac Pty Ltd 1,981,804 0.61%
Netwealth Investments Limited 1,943,357 0.60%
Ubs Nominees Pty Ltd 1,838,727 0.57%
Aglub Holdings Pty Ltd 1,733,342 0.54%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 6,368 3,805 943 1,059 167 12,342

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Elk River Holdings Pty Ltd 24/01/2024 22,675,000 7.00
HSBC Custody Nominees (Australia) Limited 24/01/2024 38,850,342 11.99
Gnosis Verwaltungsgesellschaft 24/01/2024 22,675,000 7.00
J P Morgan Nominees Australia Pty Limited 24/01/2024 34,966,849 10.79
Citicorp Nominees Pty Limited 24/01/2024 29,118,387 8.99

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $11.22 30 June
2022 $4.53 30 June
2021 $6.09 30 June
2020 $1.28 30 June
2019 $1.24 28 June
2018 $0.670 29 June
TLX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.